Article metrics

Download PDFPDF

Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study)


Online download statistics by month:

Online download statistics by month: November 2022 to October 2023

Nov 2022633620197
Dec 202250550187
Jan 202363664095
Feb 202338638775
Mar 202337336454
Apr 202341241181
May 202352852856
Jul 202358058071
Aug 202354554653
Sep 202359259851
Oct 202358559055